Results 121 to 130 of about 43,360 (234)

A Dual-Regulatory Mechanism of Estrogen on MTTPL-Mediated Hepatic Lipid Transport in Chickens: Involvement of <i>PPARα</i> and <i>miR-7439-3p</i>. [PDF]

J Agric Food Chem
Cao Y, Xia T, Jia Q, Shen Y, Shen J, Tian W, Guo Y, Kang X, Liu X, Li H.   +9 more
europepmc   +1 more source

Multivariate Regression With Dependence Structures: Evaluating Associations Between Plasma Metabolomics and Alcohol Intake in Older Adults

Statistics in Medicine, Volume 45, Issue 6-7, March 2026.
ABSTRACT High‐dimensional omics data often exhibit complex yet organized dependencies, characterized by intelligent network properties like high modularity, small‐worldness characteristics, and scale‐free topology. However, integrating these structured interdependencies between omics variables into multivariate regression models presents challenges ...
Yifan Yang, Chixiang Chen, Hwiyoung Lee, Ming Wang, Yuan Zhang, Shuo Chen   +5 more
wiley   +1 more source

Environmentally relevant lanthanum chloride exposure induces hepatic steatosis in zebrafish larvae via PPARα-dependent ApoB suppression. [PDF]

Commun Biol
Li K, Zhao X, Xie Z, Wu Q, Jia W, Zhou X, Gao X, Zeng P, Li J, Niu Q, Qi Z, Cui M, Song W.   +12 more
europepmc   +1 more source

The Impact of Metabolic Complications in Pregnancy on Later Life Maternal Cardiometabolic Health: Findings From the ROLO Longitudinal Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 739-750, March 2026.
ABSTRACT Objective To explore associations between pregnancy metabolic complications and maternal cardiometabolic health 10 years postpartum. Design Prospective Longitudinal Cohort Study following a randomised controlled trial. Setting Single‐centre. Population Pregnancy metabolic complication (pregnancy‐induced hypertension, impaired glucose tolerance,
Kristyn Dunlop, Sophie Callanan, Kaat Philippe, Catherine McNestry, Alexander Douglass, Ricardo Segurado, Rachel K. Crowley, Patrick J. Twomey, Catherine M. Phillips, Fionnuala M. McAuliffe   +9 more
wiley   +1 more source

New Methods for Calculating LDL-Cholesterol and Related Biomarkers of Atherosclerotic Cardiovascular Disease Risk. [PDF]

Curr Atheroscler Rep
Wolska A, Mansourian Y, Zubirán R, Sampson M, Remaley AT.   +4 more
europepmc   +1 more source

VLDL [PDF]

, 2019
openaire   +1 more source

The Prebiotic and Techno‐Functional Potential of Microbial Exopolysaccharides for Human Health and Food Systems

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 2, March 2026.
ABSTRACT Microbial exopolysaccharides (EPS) represent a diverse class of biopolymers holding considerable promise as functional food ingredients. This review analyzes the dual function of microbial EPS as a candidate for prebiotic agents and techno‐functional additives.
Md. Abdur Razzak, Hye Kim, Md. Ariful Haque, Min Ji Jang, Sehyeon Song, Anishka Talari, Lakshmi Devi Chittepu, Seockmo Ku   +7 more
wiley   +1 more source

Very-Low-Density Lipoproteins Quantity but Not Composition Is Altered in Normotriglyceridemic Subjects with Elevated Lipoprotein (a) Level. [PDF]

Int J Mol Sci
Wieczorek-Breitzke E, Feliksiak M, Kuchta A, Jankowski M, Ćwiklińska A.   +4 more
europepmc   +1 more source

Effects of FTO Gene rs9939609 and rs17817449 Polymorphisms on Insulin Resistance in Turkish Children With Obesity

Journal of Diabetes, Volume 18, Issue 3, March 2026.
Impact of FTO polymorphisms (rs9939609 and rs17817449) on glycemic traits, insulin homeostasis, and metabolic indicators. ABSTRACT Backgrounds Fat mass and obesity‐related gene (FTO) has been associated with glucose homeostasis and insulin sensitivity in some populations.
Merve Köksal, Mehtap Ünlü Söğüt, Sevtap Kabalı   +2 more
wiley   +1 more source

Efficacy and safety of CT‐868, a novel, fully biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double‐blind, randomized placebo controlled phase 2 trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1673-1682, March 2026.
Abstract Aims To assess the glycaemic efficacy and safety of CT‐868, a cAMP signal‐biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in participants with type 2 diabetes (T2D). Materials and Methods This 26‐week (W), phase 2, randomized, double‐blind placebo‐controlled trial enrolled adults with T2D ...
Manu V. Chakravarthy, Michael A. Elliott, Luis Acosta, Gabriele E. Sonnenberg, Damian Bialonczyk, Jingtao Wu, Federico A. Argüelles‐Tello, Raymundo Garcia‐Reza, José Gerardo González‐González, Stig K. Hansen, Juan P. Frias   +10 more
wiley   +1 more source